These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24736000)

  • 1. Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice.
    El Bissati K; Zhou Y; Dasgupta D; Cobb D; Dubey JP; Burkhard P; Lanar DE; McLeod R
    Vaccine; 2014 May; 32(26):3243-8. PubMed ID: 24736000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; El Bissati K; Zhou Y; Suzuki Y; Lee D; Woods S; Sommerville C; Henriquez FL; Roberts CW; McLeod R
    Hum Immunol; 2012 Jan; 73(1):1-10. PubMed ID: 22027386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice.
    El Bissati K; Zhou Y; Paulillo SM; Raman SK; Karch CP; Reed S; Estes A; Estes A; Lykins J; Burkhard P; McLeod R
    Sci Rep; 2020 Oct; 10(1):16984. PubMed ID: 33046728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
    Vaccine; 2011 Jan; 29(4):754-62. PubMed ID: 21095258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against
    El Bissati K; Chentoufi AA; Krishack PA; Zhou Y; Woods S; Dubey JP; Vang L; Lykins J; Broderick KE; Mui E; Suzuki Y; Sa Q; Bi S; Cardona N; Verma SK; Fraczek L; Reardon CA; Sidney J; Alexander J; Sette A; Vedvick T; Fox C; Guderian JA; Reed S; Roberts CW; McLeod R
    JCI Insight; 2016 Sep; 1(15):e85955. PubMed ID: 27699241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.
    Tan TG; Mui E; Cong H; Witola WH; Montpetit A; Muench SP; Sidney J; Alexander J; Sette A; Grigg ME; Maewal A; McLeod R
    Vaccine; 2010 May; 28(23):3977-89. PubMed ID: 20347630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of
    Guo J; Zhou A; Sun X; Sha W; Ai K; Pan G; Zhou C; Zhou H; Cong H; He S
    Front Immunol; 2019; 10():592. PubMed ID: 30984177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
    Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
    Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
    Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
    Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel HLA-B7-restricted human metapneumovirus epitopes enhance viral clearance in mice and are recognized by human CD8
    Miranda-Katz M; Erickson JJ; Lan J; Ecker A; Zhang Y; Joyce S; Williams JV
    Sci Rep; 2021 Oct; 11(1):20769. PubMed ID: 34675220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective CD8
    Ma Y; Tang K; Zhang Y; Zhang C; Cheng L; Zhang F; Zhuang R; Jin B; Zhang Y
    Virol J; 2020 Oct; 17(1):146. PubMed ID: 33028368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.
    Wang S; Wang Y; Sun X; Zhang Z; Liu T; Gadahi JA; Hassan IA; Xu L; Yan R; Song X; Li X
    BMC Infect Dis; 2015 Oct; 15():448. PubMed ID: 26497908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
    Roozbehani M; Falak R; Mohammadi M; Hemphill A; Razmjou E; Meamar AR; Masoori L; Khoshmirsafa M; Moradi M; Gharavi MJ
    Vaccine; 2018 Oct; 36(41):6124-6132. PubMed ID: 30181047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice.
    Foroutan M; Ghaffarifar F; Sharifi Z; Dalimi A
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101413. PubMed ID: 31954995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico and in vivo analysis of Toxoplasma gondii epitopes by correlating survival data with peptide-MHC-I binding affinities.
    Huang SY; Jensen MR; Rosenberg CA; Zhu XQ; Petersen E; Vorup-Jensen T
    Int J Infect Dis; 2016 Jul; 48():14-9. PubMed ID: 27109108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Protective Immune Responses Induced by Recombinant TrxLp and ENO2 Proteins against
    Wang M; Yang XY; Zhang NZ; Zhang DL; Zhu XQ
    Biomed Res Int; 2016; 2016():3571962. PubMed ID: 27803923
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice.
    Khodadadi M; Ghaffarifar F; Dalimi A; Ahmadpour E
    Acta Trop; 2021 Apr; 216():105836. PubMed ID: 33485872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.